Review
doi: 10.1038/sj.ijo.0801294.
Thyroid hormones and treatment of obesity
Affiliations
- PMID: 10997625
- DOI: 10.1038/sj.ijo.0801294
Item in Clipboard
Review
Thyroid hormones and treatment of obesity
Int J Obes Relat Metab Disord.
2000 Jun.
Abstract
Thyroid hormones have important thermogenic function. Nevertheless, thyroid dysfunctions are often associated with minor changes in body weight and fat mass. On the other hand, both overfeeding and fasting have important effects on iodothyronine metabolism and regulation of deiodinase activity. Although under debate, there are clinical and theoretical reasons to administer low-dose thyroid hormones (T3) in selected obese patients. This short review deals with both pathophysiological and clinical aspects of thyroid hormone used in the therapy of obesity.
Similar articles
-
Therapy of obesity with hormones.N Engl J Med. 1975 Jan 2;292(1):26-9. doi: 10.1056/NEJM197501022920106. N Engl J Med. 1975. PMID: 1109187 No abstract available.
-
New developments in medical therapy of obesity: thyroid and zinc.Pediatr Ann. 1984 Jun;13(6):465-72. Pediatr Ann. 1984. PMID: 6431387 No abstract available.
-
Thyroid hormones before and after weight loss in obesity.Arch Dis Child. 2002 Oct;87(4):320-3. doi: 10.1136/adc.87.4.320. Arch Dis Child. 2002. PMID: 12244007 Free PMC article.
-
Thyroid hormone and obesity.Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):408-13. doi: 10.1097/MED.0b013e328355cd6c. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22931855 Review.
-
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.Nat Rev Drug Discov. 2009 Apr;8(4):308-20. doi: 10.1038/nrd2830. Nat Rev Drug Discov. 2009. PMID: 19337272 Review.
Cited by
-
Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats.Endocrine. 2008 Apr;33(2):118-25. doi: 10.1007/s12020-008-9066-x. Epub 2008 May 1. Endocrine. 2008. PMID: 18449810
-
Pharmacological approaches for the treatment of obesity.Drugs. 2002;62(6):915-44. doi: 10.2165/00003495-200262060-00005. Drugs. 2002. PMID: 11929339 Review.
-
Prevalence of hypothyroidism in nonalcoholic fatty liver disease.Dig Dis Sci. 2012 Feb;57(2):528-34. doi: 10.1007/s10620-011-2006-2. Epub 2011 Dec 20. Dig Dis Sci. 2012. PMID: 22183820 Free PMC article.
-
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.Int J Mol Sci. 2020 Aug 18;21(16):5927. doi: 10.3390/ijms21165927. Int J Mol Sci. 2020. PMID: 32824723 Free PMC article. Review.
-
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects.Nat Commun. 2022 Dec 20;13(1):7838. doi: 10.1038/s41467-022-35470-4. Nat Commun. 2022. PMID: 36539421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical